Metlife (MET) closed at $102.65 on November 13, 2026, up 0.8% from the previous close, on volume of 2,273,817 shares (30-day average 3,130,162).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 11, 2026 | Put Spread | 21-Jan-2880 : 85 P | 4,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
TipRanks (Fri, 13-Nov 7:11 AM ET)
Business Wire (Thu, 12-Nov 9:09 AM ET)
These 10 financial stocks have stayed in Strong Buy territory for months
Seeking Alpha News (Thu, 12-Nov 8:03 AM ET)
Wells Fargo Remains a Buy on Metlife (MET)
TipRanks (Thu, 12-Nov 5:56 AM ET)
KBW Keeps Their Buy Rating on Metlife (MET)
TipRanks (Wed, 11-Nov 7:36 AM ET)
Caterpillar Could Be a Buy After Michael Burry Takes Profit
TipRanks (Tue, 10-Nov 3:29 PM ET)
MetLife Amends Credit Agreement for Up to $4 Billion
TipRanks (Tue, 10-Nov 6:36 AM ET)
Michael Burry trims Caterpillar bearish bet after puts nearly quadruple
Seeking Alpha News (Tue, 10-Nov 1:58 AM ET)
MetLife CFO John McCallion Provides Third Quarter 2026 Financial Update Video
Business Wire (Wed, 4-Nov 4:20 PM ET)
MetLife Announces 3Q 2026 Results
Business Wire (Wed, 4-Nov 4:15 PM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of November 13, 2026, MET stock price climbed to $102.65 with 2,273,817 million shares trading.
MET has a beta of 0.72, meaning it tends to be less sensitive to market movements. MET has a correlation of 0.16 to the broad based SPY ETF.
MET has a market cap of $65.23 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $20 billion in Revenue and $2.78 earnings per share. This fell short of revenue expectation by $-92 million and exceeded earnings estimates by $.02.
In the last 3 years, MET traded as high as $106.72 and as low as $61.16.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has outperformed the market in the last year with a price return of +32.1% while the SPY ETF gained +13.4%. MET has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +5.9% and +3.2%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
MET support price is $100.22 and resistance is $103.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.
